Cyclacel Pharmaceuticals, INC. (BGMSP) — 10-K Filings

All 10-K filings from Cyclacel Pharmaceuticals, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (2)

Cyclacel Pharmaceuticals Files 2024 10-K, Details Warrant Activity — Apr 2, 2025 Risk: medium
Cyclacel Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly known as XCYTE THERAPIES INC, is incorporated
Cyclacel Pharmaceuticals, Inc. Files 2023 Annual Report (10-K) — Mar 21, 2024 Risk: medium
Cyclacel Pharmaceuticals, Inc. (BGMSP) filed a Annual Report (10-K) with the SEC on March 21, 2024. Filed 10-K for the fiscal year ended December 31, 2023. Comp

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX